DICOT — Dicot Pharma AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK782.64m
- SEK713.44m
- SEK0.20m
Annual balance sheet for Dicot Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 30.3 | 9.38 | 47.3 | 113 | 69.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.001 | — | — | 4.82 | 8.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 31.7 | 12.4 | 53.5 | 124 | 85.5 |
| Net Property, Plant And Equipment | 0.028 | 0.021 | 0.013 | 0 | 0 |
| Total Assets | 31.8 | 12.4 | 53.6 | 124 | 85.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.42 | 7.01 | 9.16 | 12 | 12.1 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 3.42 | 7.01 | 9.16 | 12 | 12.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 28.4 | 5.36 | 44.4 | 112 | 73.4 |
| Total Liabilities & Shareholders' Equity | 31.8 | 12.4 | 53.6 | 124 | 85.5 |
| Total Common Shares Outstanding |